Engage-COVID-19
Engage COVID-19 was designed to document COVID-19 infection, immunity, and related determinants among gay and bisexual men (GBM). The study is part of the larger Engage Cohort Study, which investigates trends in the use of anti-retroviral-based human immunodeficiency virus (HIV) prevention. All Engage-COVID-19 participants were recruited from the larger Engage Cohort Study, resulting in over 1,800 participants at baseline from across the 3 study sites in Vancouver, Toronto, and Montreal, Canada. At baseline, participants were at least 17 years old and self-identified as GBM, including transgender GBM, who reported having sex with another man within the previous 6 months.
Study design
Cohort
Number of participants at first data collection
1,842 (participants)
Age at first data collection
≥ 17 years (participants)
Participant year of birth
Varied (participants)
Participant sex
Male
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2020
Primary Institutions
McGill University
Ryerson University (now known as Toronto University, TMU)
University of Montreal (Université de Montréal, UdeM)
University of Toronto
University of Victoria (UVic)
Profile paper DOI
Not available
Funders
COVID-19 Immunity Task Force (CITF)
Canadian Blood Services (CBS)
Canadian Foundation for AIDS Research (Fondation Canadienne De Recherche Sur Le SIDA, CANFAR)
Canadian Institutes of Health Research (CIHR, Instituts de recherche en santé du Canada, IRSC)
Ontario HIV Treatment Network (OHTN)
Ongoing?
No
Data types collected
- Interview – online
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-report questionnaire – online
- Self-report questionnaire – paper or computer assisted
- Interviews or focus groups
- None
- None
Engagement
Keywords
Consortia and dataset groups
